National Cancer Institute announced the launch of a program that offers molecular characterization of childhood cancers.
The Molecular Characterization Initiative would provide biomarker testing free of charge to children, adolescents and young adults with newly diagnosed central nervous system tumors who are receiving treatment at Children’s Oncology Group (COG)-affiliated hospitals, according to an NCI press release. Results of tumor and blood DNA and RNA analysis will help clinicians make an accurate diagnosis and determine the best possible treatment plans, including whether a child